Fishawack Health is bolstering its commercialization services offering with its largest addition yet, welcoming US policy, market access and transformation leader, Avalere.
[Image (From top left to bottom right): Avalere’s leadership team, including Kelly Brantley, Policy Practice Director; Sarah Alwardt, Healthcare Transformation Practice Director; Elizabeth Carpenter, President; Lance Grady, Market Access Practice Director; Miryam Frieder, Policy Practice Director; Rob Carter, Financial Services Practice Director.]
FH is a leading global commercialization partner for biopharmaceutical, medical technology and wellness companies. A healthcare consulting firm for more than 20 years, Avalere partners with leading life sciences companies, health plans, providers and investors to deliver innovative, patient-focused solutions. data to complex health challenges.
The move marks FH’s largest expansion to date and enables customers to benefit from integrated offerings spanning policy, access, value and evidence. The addition of more than 200 Avalere advisors strengthens FH’s presence in the American market and diversifies its clientele. “Avalere is renowned for helping clients identify business strategies that adapt to the changing healthcare landscape. From policy to market access and transformation, the team offers a 360-degree perspective that reflects the interconnected nature of the healthcare system,” said FH CEO Jon Koch. “Avalere complements Fishawack’s global footprint with a deep understanding of US markets and public policy, including key government and commercial stakeholders. We are delighted to welcome Avalere to FH.
The agreement marks another turning point in FH’s career. Founded as a medical communications agency in 2001, the company has grown into a global healthcare consulting and marketing partner offering services focused on evidence generation and access strategy, medical communications, marketing science and strategic consulting in health care.
Its capabilities are best-in-class individually, but come together in seamless, integrated offerings based on each client’s unique challenge. Its services are backed by deep expertise in data and analytics, including proprietary applications in health economics and market access, and analytics-driven digital marketing.
“We are delighted to welcome the Avalère team to the FH. They have built an outstanding customer reputation. The combination of our skills and experiences in HEOR, market access and policy will allow us to partner with customers to deliver a deeper set of integrated capabilities not offered by other companies,” says David Sykes, President of Policy, Access, Value, and Evidence at FH.
A partnership based on technology
FH and its main investor, bridge stitch, acquired Avalere from Inovalon, a leading provider of cloud-based platforms that empower data-driven healthcare. The sale will allow both Inovalon and Avalere to focus on their respective missions and objectives.
“This transaction will encourage Inovalon and Avalere to focus more on our respective key differentiators,” said Dr. Keith Dunleavy, CEO of Inovalon. “At Inovalon, the focus is on delivering the industry’s most advanced cloud-based SaaS solutions platform that empowers data-driven healthcare.”
Avalere will retain access to Inovalon’s data resources, including the AFTER2 Registration and 100% sample of the Medicare Fee-for-Service (FFS) dataset. most2 The registry includes data on more than one million physicians, nearly 600,000 clinical settings, 348 million unique patients, and 68 billion medical events.
Avalere’s health economics and advanced analytics practice will remain within Inovalon as a data solutions segment of the Inovalon Insights business unit and will continue to focus on analytics by leveraging assets proprietary data from Inovalon.
An exciting and shared future for employees, customers and consumers
“Avalere is thrilled to join FH and combine our deep understanding of the US market with a truly global perspective,” said Elizabeth Carpenter, President of Avalere. “We look forward to collaborating and innovating with our new colleagues and offering our customers a broader set of integrated services.”
FH has built a diverse and inclusive culture that fosters collaboration. Its collective teams imagine a healthier world and make the connections to get there, providing innovative solutions to the most complex health challenges.
Fishawack Health (FH) is a leading global commercialization partner for the biopharmaceutical, medtech and wellness industries. The future of healthcare is fast and complex, requiring a different approach. Established in 2001, our more than 1,300 healthcare experts combine their knowledge and expertise across our four core disciplines: medicine; Marketing; policy, access, value, evidence; and Council.
Working across the entire product and service lifecycle, from R&D to post-launch, we engage our collective strength to solve the complex healthcare challenges of today and tomorrow. We imagine a healthier world and build the connections to make it happen. Visit us atwww.fishawack.com and follow us onTwitterandLinkedIn .
In an environment that demands a 360-degree perspective, Avalere Health brings innovative, data-driven solutions to complex healthcare challenges. Avalere is a healthcare consulting firm that operates at the intersection of policy, access and transformation. We draw on vast proprietary data to derive insights and imagine what doesn’t yet exist.
Our clients span the healthcare continuum, including the top 25 life sciences companies, major health plans, major healthcare providers and healthcare investors. Knowing that the clients we work with are people first and foremost, we join them in their drive to make a difference in healthcare. Inspired by our customers, empowered by data and powered by our inclusive culture, we are the essential voice for improving healthcare. Visit us at www.avalere.com and follow us on Twitterand LinkedIn.
Inovalon is a leading provider of cloud-based solutions that empower data-driven healthcare. Inovalon ONE® The platform brings together nationwide connectivity, access to real-time primary source data, and advanced analytics in a sophisticated cloud-based platform to improve clinical outcomes and economics in the entire health ecosystem. The company’s analytics and capabilities are used by more than 20,000 customers and are informed by primary source data from more than 68 billion medical events across 1 million physicians, nearly 600,000 clinical settings and 348 million unique patients. For more information, visit www.inovalon.com.
Corporate Communications Manager
Senior Manager, Corporate Communications
Advisors involved in this transaction included:
Houlihan Lokey acted on behalf of Fishawack Health as lead financial advisor; KPMG provided financial and tax due diligence support; LEK provided business due diligence advice; Alvarez & Marsal advised separation and operational due diligence; Sheppard Mullin provided legal support; Allen & Overy provided legal advice; and EY advised on tax structuring.
Clearsight Advisors acted as exclusive financial advisor to Inovalon in connection with this transaction. Rimon Law served as exclusive legal counsel to Inovalon on this transaction.